Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

J&J bets $1.75 billion on virology

October 1, 2014 Research and Development, Sales and Marketing AL-8176, Alios BioPharma, J&J, JJ, Janssen, sovaldi, viral

Johnson & Johnson has signed a deal to acquire Alios BioPharma, a privately-held company focussed on developing therapies for viral …
News

Chemia appoints network manager

October 1, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Creston Health, Duncanson-Hunter, Pan, Red Door, chemia

Creston Health-owned network of agencies offering Chemia has hired a manager to run its operations. Ellie Duncanson-Hunter has been appointed …
Appointment

SHL to introduce product Case Studies at the 2014 PDA Conference

October 1, 2014 Sales and Marketing auto injectors, case studies, pen injectors, shl group

Taking an advanced injection device from concept to reality requires careful planning, key design and manufacturing competencies and a thorough …
Feature
Thought Leadership

Boehringer spends €100 million on inhaler

September 30, 2014 Manufacturing and Production, Sales and Marketing Boehringer, Germany, Spiriva, Striverdi, inhaler, olodaterol, respimat

Boehringer Ingelheim is to spend more than €100 million at its Dortmund site in Germany in order to expand the …
News

UK to ‘guarantee’ seven-day access to GPs

September 30, 2014 Medical Communications, Research and Development, Sales and Marketing BMA, Cameron, GPs, NHS, UK, doctors

Under a UK Conservative government everyone would have access to GP care seven days a week as well as a …
News

New director for NHS England

September 30, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS England, richard jeavons

Richard Jeavons will be joining NHS England as its new director of specialised commissioning. Jeavons will report to Dame Barbara …
Appointment

Lucideon expands pharma testing facilities

September 29, 2014 Manufacturing and Production, Sales and Marketing bioburden, ceram, freeman, labs, lucideon, manufacturing, stoke

Materials development firm Lucideon has opened new pharmaceutical quality control testing laboratories at its UK headquarters in Stoke-on-Trent. The £1.5 …
News

BMS therapeutic cancer vaccine given swift FDA appraisal

September 29, 2014 Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, FDA, Vaccine, bristol myers-squibb, keytruda, melanoma, opdivo

Bristol-Myers Squibb has been granted a speedy review for its new cancer immunotherapy drug Opdivo by the FDA for patients …
News

Boehringer’s lung cancer drug gets EMA nod

September 29, 2014 Sales and Marketing Boehringer, IPF, docetaxel, ingelheim, lung cancer, nintedanib

The EMA has issued a positive opinion for the approval of Boehringer Ingelheim’s nintedanib in combination with docetaxel for the …
News

NHS stem cell research link up

September 29, 2014 Research and Development, Sales and Marketing NHS, precious cells group, precious cells miracle, stem cell

Precious Cells Miracle, the charitable arm of stem cell firm Precious Cells Group, has partnered with the Croydon Health Services …
News

Sovaldi combo sees CHMP green light

September 29, 2014 Sales and Marketing CHMP, EU, Gilead, HCV, harvoni, hep C, sovaldi

The CHMP is recommending that Gilead’s new combination hepatitis C drug therapy Harvoni should be approved for use across the …
News

Roche’s Perjeta sees ‘impressive’ survival rates

September 29, 2014 Sales and Marketing Cancer, ESMO, Perjeta, Roche, breast, madrid

Roche’s oncology drug Perjeta combined with other medicines can help certain breast cancer patients live longer. This is according to …
News

Daiichi Sankyo pays $410m for Ambit Biosciences

September 29, 2014 Sales and Marketing AML, Daiichi Sankyo, ambit biosciences, quizartinib

Daiichi Sankyo has bought San Diego-based Ambit Biosciences in a deal aimed at shoring up the Japanese company’s cancer research. …
News

Adaptimmune board changes amid funding boost

September 29, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adaptimmune, Ali Behbahani, Elliott Sigal, Peter Thompson, david mott

Oxford-based biotech firm Adaptimmune has secured some significant financial support whilst also making changes to its board. David Mott (pictured), …
Appointment

Is clinical research management evidence-based?

September 29, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, Six Sigma, clinical trials, evidence, neuro-linguistic

Those who follow my columns will know that I am in the habit of starting with reminiscences. It’s something that …
Feature
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026